Quick Takeaways
- JANUS HENDERSON GROUP PLC filed SCHEDULE 13G for CAMP4 THERAPEUTICS CORP Common Stock (CAMP).
- Disclosed ownership: 12%.
- Date of event: 31 Dec 2025.
JANUS HENDERSON GROUP PLC - 31 Dec 2025 SCHEDULE 13G Report for CAMP4 THERAPEUTICS CORP Common Stock (CAMP)
- Filing Manager
- JANUS HENDERSON GROUP PLC
- Reporting Manager
- JANUS HENDERSON GROUP PLC
- Security
- CAMP4 THERAPEUTICS CORP Common Stock
- Symbol
- CAMP
- Shares outstanding
- 51,701,934 shares
- Disclosed Ownership
- 6,307,636 shares
- Ownership
- 12%
- Form type
- SCHEDULE 13G
- Filing time
- 08 Jan 2026, 12:15:25 UTC
- Date of event
- 31 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"JANUS HENDERSON GROUP PLC disclosed 12% ownership in CAMP4 THERAPEUTICS CORP Common Stock (CAMP) on 31 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 08 Jan 2026, 12:15.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 12% | 6,307,636 | 0 | 6,307,636 | Kristin Mariani | Head of North America Compliance, CCO |